Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents

Mutant isocitrate dehydrogenase (IDH) 2 "IDH2m" acquires a neo-enzymatic activity reducing α-ketoglutarate to an oncometabolite, D-2-hydroxyglutarate (2-HG). Three s-triazine series were designed and synthesised using enasidenib as a lead compound. In vitro anticancer screening via Nationa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ahmed F. Khalil (Auteur), Tarek F. El-Moselhy (Auteur), Eman A. El-Bastawissy (Auteur), Rasha Abdelhady (Auteur), Nancy S. Younis (Auteur), Mervat H. El-Hamamsy (Auteur)
Formaat: Boek
Gepubliceerd in: Taylor & Francis Group, 2023-12-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar